{
    "ok": true,
    "doi": "10.1192\/bjp.bp.116.182865",
    "status": "found",
    "title": "Acceptance and commitment therapy for psychosis: Randomised controlled trial",
    "authors": [
        "Frances Shawyer",
        "John Farhall",
        "Neil Thomas",
        "Steven C. Hayes",
        "Robert Gallop",
        "David Copolov",
        "David J. Castle"
    ],
    "container": "British Journal of Psychiatry",
    "year": "2017",
    "doi_url": "https:\/\/doi.org\/10.1192\/bjp.bp.116.182865",
    "is_open_access": true,
    "oa_status": "bronze",
    "best_landing_page": "https:\/\/pubmed.ncbi.nlm.nih.gov\/27979820",
    "best_pdf": "https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/654E99ED1B262FB11D6F5D738ABCF592\/S0007125000279713a.pdf\/div-class-title-acceptance-and-commitment-therapy-for-psychosis-randomised-controlled-trial-div.pdf",
    "abstract": "BACKGROUND: The efficacy of acceptance and commitment therapy (ACT) in psychosis has been reported but not for medication-resistant psychosis. AIMS: To test the efficacy of ACT in a sample of community-residing patients with persisting psychotic symptoms. (Australian New Zealand Clinical Trials Registry: ACTRN12608000210370.) METHOD: The primary outcome was overall mental state at post-therapy (Positive and Negative Syndrome Scale - total); secondary outcomes were psychotic symptom dimensions and functioning. In total, 96 patients were randomised to ACT (n = 49) or befriending (n = 47). Symptom, functioning and process measures were administered at baseline, post-therapy and 6 months later. RESULTS: There was no group difference on overall mental state. In secondary analyses the ACT group showed greater improvement in positive symptoms and hallucination distress at follow-up: Cohen's d = 0.52 (95% CI 0.07-0.98) and 0.65 (95% CI 0.24-1.06), respectively. CONCLUSIONS: Improvements reflected the treatment focus on positive symptoms; however, absence of process-measure changes suggests that the ACT intervention used did not manipulate targeted processes beyond befriending. Symptom-specific therapy refinements, improved investigation of process and attention to cognitive functioning and dose are warranted in future research.",
    "abstract_notice": null,
    "locations": [
        {
            "source": "The British Journal of Psychiatry",
            "landing_page_url": "https:\/\/doi.org\/10.1192\/bjp.bp.116.182865",
            "pdf_url": "https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/654E99ED1B262FB11D6F5D738ABCF592\/S0007125000279713a.pdf\/div-class-title-acceptance-and-commitment-therapy-for-psychosis-randomised-controlled-trial-div.pdf",
            "is_oa": true,
            "version": "publishedVersion"
        },
        {
            "source": "PubMed",
            "landing_page_url": "https:\/\/pubmed.ncbi.nlm.nih.gov\/27979820",
            "pdf_url": null,
            "is_oa": false,
            "version": "publishedVersion"
        },
        {
            "source": "Swinburne figshare (Swinburne University of Technology)",
            "landing_page_url": "http:\/\/hdl.handle.net\/1959.3\/435137",
            "pdf_url": null,
            "is_oa": false,
            "version": "submittedVersion"
        }
    ],
    "crossref_links": [
        {
            "url": "https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000279713",
            "content_type": "unspecified",
            "version": "vor",
            "intended_application": "similarity-checking"
        }
    ],
    "pubmed_search": "https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=10.1192%2Fbjp.bp.116.182865",
    "google_scholar": "https:\/\/scholar.google.com\/scholar?q=Acceptance%20and%20commitment%20therapy%20for%20psychosis%3A%20Randomised%20controlled%20trial"
}